肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

卵巢恶性肿瘤诊断与治疗指南（第四版）

2018-07-10 中国抗癌协会妇科肿瘤专业委员会 中国实用妇科与产科杂志.2018,34(7):739-749.

卵巢恶性肿瘤卵巢癌

卵巢恶性肿瘤为妇科恶性肿瘤发病的第3位，尚未找到有效的早期筛查方法，治疗后复发率高。近年来，聚腺苷二磷酸-核酸聚合酶（PARP）抑制剂治疗上皮性卵巢癌取得显著进展。

中文标题：

卵巢恶性肿瘤诊断与治疗指南（第四版）

发布机构：

中国抗癌协会妇科肿瘤专业委员会

发布日期：

2018-07-10

简要介绍：

卵巢恶性肿瘤为妇科恶性肿瘤发病的第3位，尚未找到有效的早期筛查方法，治疗后复发率高。近年来，聚腺苷二磷酸-核酸聚合酶（PARP）抑制剂治疗上皮性卵巢癌取得显著进展。 

拓展指南：与卵巢癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=卵巢恶性肿瘤诊断与治疗指南（第四版）)] GetToolGuiderByIdResponse(projectId=1, id=29dbd1c001616548, title=卵巢恶性肿瘤诊断与治疗指南（第四版）, enTitle=, guiderFrom=中国实用妇科与产科杂志.2018,34(7):739-749., authorId=null, author=, summary=卵巢恶性肿瘤为妇科恶性肿瘤发病的第3位，尚未找到有效的早期筛查方法，治疗后复发率高。近年来，聚腺苷二磷酸-核酸聚合酶（PARP）抑制剂治疗上皮性卵巢癌取得显著进展。 , cover=, journalId=null, articlesId=null, associationId=1526, associationName=中国抗癌协会妇科肿瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jul 10 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>卵巢恶性肿瘤为妇科恶性肿瘤发病的第3位，尚未找到有效的早期筛查方法，治疗后复发率高。近年来，聚腺苷二磷酸-核酸聚合酶（PARP）抑制剂治疗上皮性卵巢癌取得显著进展。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>卵巢癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=7aaff1c001616222" title="2018年欧洲肿瘤内科学会《非上皮性卵巢癌诊断、治疗和随访临床实践指南》解读" target=_blank>2018年欧洲肿瘤内科学会《非上皮性卵巢癌诊断、治疗和随访临床实践指南》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fc5231c00161526e" title="NCCN临床实践指南：遗传/家族高风险评估-乳腺癌和卵巢癌（2019.V1）" target=_blank>NCCN临床实践指南：遗传/家族高风险评估-乳腺癌和卵巢癌（2019.V1）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5c00f1c001596946" title="《2018 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南》解读" target=_blank>《2018 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3e01f1c00159a26f" title="2018 KSGO共识声明：卵巢癌的管理指南" target=_blank>2018 KSGO共识声明：卵巢癌的管理指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5a5701c00158a844" title="2018 ESMO临床实践指南：非上皮性卵巢癌的诊断，治疗和随访" target=_blank>2018 ESMO临床实践指南：非上皮性卵巢癌的诊断，治疗和随访</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%8D%B5%E5%B7%A2%E7%99%8C" target=_blank>有关卵巢癌更多指南</a></ul>, tagList=[TagDto(tagId=45436, tagName=卵巢恶性肿瘤), TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6055, appHits=479, showAppHits=0, pcHits=3890, showPcHits=2782, likes=120, shares=21, comments=3, approvalStatus=1, publishedTime=Tue Jul 17 21:23:55 CST 2018, publishedTimeString=2018-07-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 17 21:23:55 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:15:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=卵巢恶性肿瘤诊断与治疗指南（第四版）)])
卵巢恶性肿瘤诊断与治疗指南（第四版）
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=899971, encodeId=a8138999e15a, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erq8lvN2LnMUaf6ibWNicLkapibsxIFoFkpZ8RKbe974wWzm8gvk5Crtt18eB2YPNtptngHa1bqPFNGg/132, createdBy=e5561970525, createdName=yulan123, createdTime=Tue Nov 17 19:43:39 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332322, encodeId=7bf9332322c1, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 17 22:15:08 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332315, encodeId=b8da3323158c, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 17 21:59:25 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2020-11-17 yulan123

    很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=899971, encodeId=a8138999e15a, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erq8lvN2LnMUaf6ibWNicLkapibsxIFoFkpZ8RKbe974wWzm8gvk5Crtt18eB2YPNtptngHa1bqPFNGg/132, createdBy=e5561970525, createdName=yulan123, createdTime=Tue Nov 17 19:43:39 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332322, encodeId=7bf9332322c1, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 17 22:15:08 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332315, encodeId=b8da3323158c, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 17 21:59:25 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2018-07-17 1e1b8538m79(暂无匿称)

    不错的文章值得拥有

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=899971, encodeId=a8138999e15a, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erq8lvN2LnMUaf6ibWNicLkapibsxIFoFkpZ8RKbe974wWzm8gvk5Crtt18eB2YPNtptngHa1bqPFNGg/132, createdBy=e5561970525, createdName=yulan123, createdTime=Tue Nov 17 19:43:39 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332322, encodeId=7bf9332322c1, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jul 17 22:15:08 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332315, encodeId=b8da3323158c, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jul 17 21:59:25 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2018-07-17 惠映实验室

    学习了谢谢分享

    0